muscle soreness; This is a spontaneous report from a contactable healthcare professional. An adult female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 07Jan2021 in left arm at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient had historical vaccine of first dose of BNT162B2 on unspecified date. The patient had no allergies to medications, food, or other products. On 07Jan2021, the patient experienced muscle soreness the day of the injection. No other symptoms were reported. No treatment was given to the patient for the event. The outcome of the event was unknown. The facility where the most recent COVID-19 vaccine was administered was in the hospital. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, it was unknown if the patient was tested for COVID-19. The event was considered non serious as it did not results in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.